infusion has been the constant development of what appears to be an "inflammatory reaction" in the arm vein.
Introduction
Oral contraception with conventional oestrogen-progestogen combinations produces significant increases in blood-clotting factors (Thomson and Poller, 1965; Poller et al., 1968) and in the rate of platelet aggregation after three months (Poler et al., 1969a) . These changes were not found in women after progestogen-only contraception with chlormadinone acetate. Increased rates of blood clotting and platelet aggregation from oestrogen-progestogen combinations rapidly returned to normal when this progestogen was substituted (Poller et (Poller et al., 1969a (Poller et al., , 1969b , except that the platelet aggregation studies were set up within 15 minutes of venepuncture.
The following tests were performed at each visit: prothrombin time, cephalin time, and factors VII and X assays. Platelet aggregation (Chandler's tube technique) and a quantitative fibrinogen assay (Ratnoff and Menzie, 1951) Coagulation Studies.-The prothrombin time and cephalin time of the progestogen group and controls showed no significant difference at any stage. Comparison of the two progestogen groups (1 and 2) at six months indicated that there was no difference at this time between those who had started on progestogen and those who had changed over from a combined preparation. Factor X levels, which our previous report showed were still significantly raised at three months in the group who had changed from combined preparations, became normal after six monthly cycles on chlormadinone acetate. Results of the two groups have therefore been combined from the six-month period. Factors VII and X results are given in Table I . Chlormadinone acetate has given no significant The discovery of accelerated platelet aggregation after two years on the progestogen is a worrying feature, but some reassurance may be obtained from a parallel study which is in progress on combined oestrogen-progestogen preparations. The increased rate of platelet aggregation recorded in our progestogen groups is still significantly less than with the combined preparations.
The thromboelastograph studies were available only in the group who had not previously taken an oral contraceptive preparation. Thromboelastography gives a measure of overall "intrinsic" clotting, platelet function, and fibrinolysis. The findings are therefore non-specific but do confirm the trend towards "hypercoagulability." Like the changes in platelet aggregation, alterations in thromboelastograph patterns are proving to be less pronounced than in our concurrent longterm study of combined oestrogen-progestogen preparations. With combined preparations the maximum amplitude value (ma) also is increased. This increase in ma, in addition, occurs with venous thrombosis and postexercise hypercoagulability .
It is interesting to speculate on the reasons for the discrepant findings in the coagulation tests and platelet aggregation. The platelet-clotting system involved in Chandler's tube platelet aggregation is believed to require smaller amounts of thrombin than the blood-clotting mechanism, and it is possible, therefore, that the technique may pick out acceleration of clotting before it can be detected by coagulation tests. Alternatively, the changes in Chandler's tube may be a specific effect on platelet aggregation not reflected in the coagulation tests. The return of platelet aggregation to normal occurs much quicker than the reversal of the altered levels of clotting factors, suggesting that the mechanism may not be simply related to measurable amounts of clotting factors in the blood.
Conclusion
Chlormadinone acetate may be an advance on conventional oestrogen-progestogen oral contraception. Effects on clotting factors have not been recorded with up to two years' administration. Platelet aggregation changes appear later and are significantly less pronounced than with combined preparations. Thromboelastograph patterns are not as abnormal as with combined oral contraception. Further follow-up is required to establish whether the increased rate of platelet aggregation and altered thromboelastograph patterns become more abnormal. It is interesting to speculate on the reason for delayed alteration in platelet aggregation and thromboelastography. This may result from the body's adjustment to large amounts of exogenous progestogen. It is also important to determine whether these less pronounced changes are reflected in significantly diminished risk of clinical thrombosis. This will have to be demonstrated by clinical study, assuming that the drug again becomes generally available.
The absence of any rise in clotting factors and the fact that raised clotting factors from combined preparations returned to normal and remained normal over the two-year period of study are encouraging features of progestogen-only contraception with chlormadinone acetate.
Introduction
Prolonged consumption of analgesic drugs is known to impair renal function (Nanra and Kincaid-Smith, 1970 ) but the acute effects of these drugs are unknown. Conventional methods for assessing glomerular filtration are either tedious to perform or too inaccurate to detect short-lived changes in renal function. Recent papers (Chantler, Garnett, Parsons, and Veall, 1969) have suggested that a single-injection technique by which renal clearance is calculated from the plasma disappearance of a radioactive substance correlates well with inulin clearance and is highly reproducible. We have therefore used the clearance of sodium l5I-diatrizoate (Hypaque) to study the acute effects of aspirin on glomerular filtration rate.
Patients and Methods
Fifteen medical inpatients were studied. All were informed of the nature and purpose of the studies and gave their consent. None had any impairment of renal function and all patients were in a steady state. All studies were performed at the same time of day and under the same conditions.
For the measurement of clearance a dose of radioactive 
